Short-course High-dose Prednisone and Dexamethasone in Children With ITP — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Short-course High-dose Prednisone and Dexamethasone in Children With ITP — Stella

Home/Immune Thrombocytopenia/

View on ClinicalTrials.gov

Recruiting

Back to Immune Thrombocytopenia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

Children with newly dignosed ITP, Fujian, Fujian

Key details

Phase

Post-approval study

Sponsor

Fujian Medical University Union Hospital

Collaborators

The First Affiliated Hospital of Xiamen University, Zhangzhou Affiliated Hospital of Fujian Medical University

Enrollment target

~608 participants

Started

October 2022

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

29 Days – 14 Years

Last updated May 2024